Researchers in Shanghai report a potential therapeutic based on Prussian blue to tackle Parkinson’s disease.

Researchers in Shanghai report a potential therapeutic based on Prussian blue to tackle Parkinson’s disease.
A new experimental mRNA therapy for idiopathic pulmonary fibrosis has done what no current treatment options can do.
From boosterless vaccine platforms to goopy 2D inks and color-changing crystals, here are some of the most striking images collected from our journals.
3D-printed structures can be built inside synthetic cells without opening or damaging them.
Predicting the properties of materials made easier through an understanding of their curvilinear geometries.
A natural chemical tether helps researchers attach cells to inert biomaterials for better cell models and therapies.
To help combat antibiotic resistance, scientists have developed a biosensor for more efficient and controlled administration of antibiotics.
This implantable device acts as mechanical support for damaged tendons and mimics the bioelectrical cues usually provided by collagen during wound healing.
Using atomically-thin 2D films, researchers have developed a nano-scale random number generator with enhanced long-term stability and reduced power consumption.
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.